Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Versicor and Pharmacia & Upjohn join forces for development of new oxazolidinones

April 9, 1999

FDA decides to continue review of Relenza NDA

April 8, 1999

Production and activity of new antimicrobial compound described by Teijin

April 8, 1999

Novel antibiotic active against acid-fast bacteria presented at recent Japanese congress

April 7, 1999

New carbapenems synthesized at Merck useful against resistant staphylococci

April 7, 1999

International team identifies myristic acid analogues with antipicornaviral activity

March 31, 1999

In vitro and in vivo profile of SB-265805 discussed at European microbiology meeting

March 31, 1999

Emoxipin analogues studied by Russian team in animal models of infection

March 31, 1999

Kyorin describes production, synthesis and structure of novel antibacterial substance

March 31, 1999

Liposomal antiseptic enters clinical testing at Mundipharma

March 31, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...